Mario E. Valdés‐Tresanco

3.4k total citations · 1 hit paper
24 papers, 2.1k citations indexed

About

Mario E. Valdés‐Tresanco is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mario E. Valdés‐Tresanco has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mario E. Valdés‐Tresanco's work include Peptidase Inhibition and Analysis (10 papers), Protein Structure and Dynamics (6 papers) and Computational Drug Discovery Methods (5 papers). Mario E. Valdés‐Tresanco is often cited by papers focused on Peptidase Inhibition and Analysis (10 papers), Protein Structure and Dynamics (6 papers) and Computational Drug Discovery Methods (5 papers). Mario E. Valdés‐Tresanco collaborates with scholars based in Cuba, Canada and Colombia. Mario E. Valdés‐Tresanco's co-authors include Ernesto Moreno, Pedro A. Valiente, Mario S. Valdés‐Tresanco, Jean‐Louis Charli, Belinda Sánchez Pérez, Bernhard Westermann, Aldrin V. Vasco, Daniel G. Rivera, Carmen Soto and William L. Scott and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Physical Chemistry B and Scientific Reports.

In The Last Decade

Mario E. Valdés‐Tresanco

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS

2021 1.6k citations Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco et al. profile →

Peers

Countries citing papers authored by Mario E. Valdés‐Tresanco

Since Specialization

Citations

This map shows the geographic impact of Mario E. Valdés‐Tresanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario E. Valdés‐Tresanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario E. Valdés‐Tresanco more than expected).

Fields of papers citing papers by Mario E. Valdés‐Tresanco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario E. Valdés‐Tresanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario E. Valdés‐Tresanco. The network helps show where Mario E. Valdés‐Tresanco may publish in the future.

Co-authorship network of co-authors of Mario E. Valdés‐Tresanco

This figure shows the co-authorship network connecting the top 25 collaborators of Mario E. Valdés‐Tresanco. A scholar is included among the top collaborators of Mario E. Valdés‐Tresanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario E. Valdés‐Tresanco. Mario E. Valdés‐Tresanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and Validation of Compounds Targeting Leishmania major Leucyl-Aminopeptidase M17 2024 ·ACS Infectious Diseases ·(unknown), Sandra Carvalho, Mario E. Valdés‐Tresanco, De Lin, (unknown), Victoriano Corpas‐López, Martina Tesařová, Julius Lukeš, David W. Gray, (unknown), Susan Wyllie, Mark C. Field	3
2	Assessment of Different Parameters on the Accuracy of Computational Alanine Scanning of Protein–Protein Complexes with the Molecular Mechanics/Generalized Born Surface Area Method 2023 ·The Journal of Physical Chemistry B ·Mario E. Valdés‐Tresanco, Mario S. Valdés‐Tresanco, Ernesto Moreno, Pedro A. Valiente	13
3	Structural Modeling of Nanobodies: A Benchmark of State-of-the-Art Artificial Intelligence Programs 2023 ·Molecules ·Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco, (unknown), Ernesto Moreno	15
4	Unveiling Sticholysin II and plasmid DNA interaction: Implications for developing non-viral vectors 2023 ·Toxicon ·(unknown), (unknown), (unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), (unknown), (unknown), Belinda Sánchez Pérez, Carlos Álvarez, Leandro R.S. Barbosa, Rosângela Itri, María E. Lanio	0
5	NbThermo: a new thermostability database for nanobodies 2023 ·Database ·Mario S. Valdés‐Tresanco, (unknown), Mario E. Valdés‐Tresanco, (unknown), Ernesto Moreno	21
6	Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer 2023 ·Physical Sciences Reviews ·(unknown), (unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), (unknown), (unknown)	1
7	Mammalian aminopeptidase A: biochemical characteristics, physiological roles and physiopathological implications 2023 ·Pure and Applied Chemistry ·(unknown), (unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), (unknown), (unknown), (unknown), (unknown)	0
8	Bufadienolides preferentially inhibit aminopeptidase N among mammalian metallo-aminopeptidases; relationship with effects on human melanoma MeWo cells 2022 ·International Journal of Biological Macromolecules ·(unknown), (unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), Wilmer H. Perera, (unknown), (unknown), (unknown), Jean‐Louis Charli	11
9	Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV 2021 ·International Journal of Biological Macromolecules ·(unknown), Pedro A. Valiente, Mario E. Valdés‐Tresanco, (unknown), (unknown), (unknown), (unknown), Osmany Guirola, D. Pastor, (unknown), Belinda Sánchez Pérez, Jean‐Louis Charli	7
10	The origin and radiation of the phosphoprotein phosphatase (PPP) enzymes of Eukaryotes 2021 ·Scientific Reports ·David Kerk, (unknown), Mario E. Valdés‐Tresanco, Sergei Y. Noskov, Kenneth Ng, Greg B. G. Moorhead	4
11	Origin of the Phosphoprotein Phosphatase (PPP) sequence family in Bacteria: Critical ancestral sequence changes, radiation patterns and substrate binding features 2021 ·SHILAP Revista de lepidopterología ·David Kerk, Mario E. Valdés‐Tresanco, (unknown), Sergei Y. Noskov, Kenneth Ng, Greg B. G. Moorhead	4
12	AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4 2020 ·Biology Direct ·Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco, Pedro A. Valiente, Ernesto Moreno	239
13	Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability 2020 ·International Journal of Biological Macromolecules ·(unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), (unknown), Belinda Sánchez Pérez, Jean‐Louis Charli, (unknown)	14
14	Understanding the disrupting mechanism of the Tau aggregation motif “³⁰⁶VQIVYK³¹¹” by phenylthiazolyl‐hydrazides inhibitors 2020 ·Journal of Molecular Recognition ·(unknown), (unknown), Mario E. Valdés‐Tresanco, Luís A. Montero, Ernesto Moreno, Pedro A. Valiente	7
15	Membrane Remodeling by the Lytic Fragment of SticholysinII: Implications for the Toroidal Pore Model 2019 ·Biophysical Journal ·(unknown), Pedro A. Valiente, Mario E. Valdés‐Tresanco, Raquel F. Epand, María E. Lanio, Richard M. Epand, Carlos Álvarez, D. Peter Tieleman, Uris Ros	12
16	Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer’s Disease 2019 ·ACS Chemical Neuroscience ·Deborah Doens, Mario E. Valdés‐Tresanco, Velmarini Vasquez, María B. Carreira, Yila de la Guardia, David E. Stephens, Viet D. Nguyen, Vu T. Nguyen, Jianhua Gu, Muralidhar L. Hegde, Oleg V. Larionov, Pedro A. Valiente, Ricardo Lleonart, Patricia L. Fernández	13
17	Bacitracin is a non-competitive inhibitor of porcine M1 family neutral and glutamyl aminopeptidases 2019 ·Natural Product Research ·(unknown), (unknown), (unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), Jean‐Louis Charli, Belinda Sánchez Pérez, (unknown)	7
18	Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent solid-phase synthesis of tetrazole-peptidomimetics 2018 ·European Journal of Medicinal Chemistry ·Yanira Méndez, (unknown), (unknown), (unknown), Mario E. Valdés‐Tresanco, (unknown), (unknown), (unknown), Pedro A. Valiente, Carmen Soto, (unknown), Aldrin V. Vasco, William L. Scott, Bernhard Westermann, (unknown), Daniel G. Rivera	30
19	Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN) 2017 ·Biochimie ·(unknown), Pedro A. Valiente, (unknown), Mario E. Valdés‐Tresanco, (unknown), (unknown), Lotfi Bounaadja, Rosa María Uribe, (unknown), Isabelle Florent, Jean‐Louis Charli	13
20	Protein surface roughness accounts for binding free energy of Plasmepsin II‐ligand complexes 2017 ·Journal of Molecular Recognition ·Mario E. Valdés‐Tresanco, Mario S. Valdés‐Tresanco, Pedro A. Valiente, G. Cocho, Ricardo Mansilla, J.M. Nieto‐Villar	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact